NASDAQ : MLEC

Moolec Science S.A.

$6.5401 USD

-$0.46 (-6.57%)

Volume
2.75K
Average Volume
80.51K
Market Capitalization
$4.75M
P/E Ratio
-0.03
Dividend Yield
0.00%
Price Target
$45.00
Year High
$59.85
Year Low
$3.08
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.13
Company Overview

NASDAQ

Alejandro Antalich

Biotechnology

Healthcare

MLEC

103

KY

USD

352 26 49 65 65

G6223S125

0001937737

Liquidity Metrics

-3.74

0.13

0.12

0.00

0.00

Sales & Valuation

$333.61M

0.01

-0.04

-0.16

-69.87

Profitability

-$258.75

-$111.46M

-33.41%

-50.96%

376.84%

-54.45%

P/E Metrics

-0.03

0.00

0.00

Analyst Price Target & Rating

$45.00

$45.00

$45.00

Strong Sell

1/5

1 Analysts

-85.47%

Poll Results

About Moolec Science S.A. (NASDAQ:MLEC) Stock

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands. ...

Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States

2026-05-14 09:00:00

WARWICK, GB / ACCESS Newswire / May 14, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the 2026 commercial planting campaign for its GLASO1 safflower program focused on the production of high-GLA ("Gamma-Linolenic Acid") specialty oils for industrial and advanced ingredient applications. "Today represents a defining moment for Moolec.

Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period

2026-05-13 18:35:00

GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / May 13, 2026 / As previously reported on January 29, 2026, Moolec Science SA ("Moolec" and/or the "Company"), received written notice from the Nasdaq Hearings Panel (the "Panel") informing the Company that the Panel had granted the Company's request for an extension to regain compliance with the continued listing requirements of The Nasdaq Stock Market LLC, specifically with respect to the minimum stockholders' equity requirement. The Company announced today that it has submitted information required to demonstrate compliance with the Nasdaq Capital Market's stockholders' equity requirement within the remediation period granted by the Panel.

Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications

2026-04-29 09:03:00

WARWICK, UK / ACCESS Newswire / April 29, 2026 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the first phase of industrialization of its GLASO1 safflower platform, following a 2025 campaign that materially exceeded all internal forecasts. Building on previously reported results confirming approximately 45% GLA ("Gamma-linolenic acid") concentration at commercial scale, the Company has now validated not only agronomic and processing performance, but also the industrial-scale handling and availability of high-purity GLA output, marking a critical step toward full commercial deployment.

Frequently Asked Questions

What is the current Moolec Science S.A. (MLEC) stock price?

Moolec Science S.A.(NASDAQ:MLEC) stock price is $6.5401 in the last trading session. During the trading session, MLEC stock reached the peak price of $59.85 while $3.075 was the lowest point it dropped to. The percentage change in MLEC stock occurred in the recent session was --6.57% while the dollar amount for the price change in MLEC stock was -$0.46.

MLEC's industry and sector of operation?

The NASDAQ listed MLEC is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of MLEC?

Paola Díaz Dellavalle | Chief Technology Officer
Henk Hoogenkamp | Co-Founder & Chief Product Officer
Martin Salinas | Co-Founder
Catalina Jones | Chief of Staff & Sustainability
Amit Dhingra | Chief Science Officer

How many employees does MLEC have?

Number of MLEC employees currently stands at 103. MLEC operates from 89 Nexus Way, Grand Cayman, LU KY1-9009, KY.

Link for MLEC official website?

Official Website of MLEC is: https://www.moolecscience.com

How do I contact MLEC?

MLEC could be contacted at phone #352 26 49 65 65 and can also be accessed through its website. MLEC operates from 89 Nexus Way, Grand Cayman, LU KY1-9009, KY.

How many shares of MLEC are traded daily?

The average number of MLEC shares traded daily for last 3 months was 80.51K.

What is the market cap of MLEC currently?

The market value of MLEC currently stands at $4.75M with its latest stock price at $6.5401